Prostacyclin signaling regulates circulating ghrelin during acute inflammation

Lisa D. Madison, Jarrad M. Scarlett, Peter Levasseur, XinXia Zhu, Kenneth Newcomb, Ayesha Batra, Darren Bowe, Daniel Marks

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Ghrelin is an octanoylated 28 amino acid peptide predominantly secreted by the stomach, and has potent stimulatory effects on appetite. Several laboratories, including our own, have demonstrated that ghrehn levels fall in states of acute inflammation brought about by injection of bacterial lipopolysaccharide (LPS). We now demonstrate that the decrease in circulating ghrelin is not due to a decrease in ghrelin gene expression, but is instead likely to be due to an acute decrease in ghrelin secretion. Furthermore, we have found that the change in circulating ghrelin during acute inflammation required a prostaglandin second messenger, but did not require the synthesis of nitric oxide. Interestingly, i.v. injection of prostaglandin E2 failed to decrease circulating ghrelin levels, whereas prostacyclin decreased circulating ghrelin to a similar extent as did LPS. We also provide anatomical evidence for the mechanism of the regulation of ghrelin by inflammation. We demonstrate that the type 1 interleukin-1β (IL-1β) receptor is expressed within the gastric mucosa, but is not expressed by ghrelin cells. The prostacyclin receptor was also expressed in the gastric mucosa, and the majority of ghrelin-producing cells were found to co-express this receptor. Mice with genetic deletion of the type 1 IL-1 receptor do not suppress circulating ghrelin levels with LPS administration. Collectively, these data support a model in which the mechanism of inflammation induced decreases in ghrelin are due to the action of IL-1β on cells within the gastric mucosa that in turn produce prostacyclin as a second messenger. These data provide further support for the potential role of ghrelin as a therapeutic agent in acute and chronic inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)263-273
Number of pages11
JournalJournal of Endocrinology
Volume196
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Ghrelin
Epoprostenol
Inflammation
Interleukin-1 Type I Receptors
Gastric Mucosa
Lipopolysaccharides
Second Messenger Systems
Epoprostenol Receptors
Injections
Appetite
Interleukin-1
Dinoprostone
Prostaglandins
Stomach
Nitric Oxide
Chronic Disease

ASJC Scopus subject areas

  • Endocrinology

Cite this

Madison, L. D., Scarlett, J. M., Levasseur, P., Zhu, X., Newcomb, K., Batra, A., ... Marks, D. (2008). Prostacyclin signaling regulates circulating ghrelin during acute inflammation. Journal of Endocrinology, 196(2), 263-273. https://doi.org/10.1677/JOE-07-0478

Prostacyclin signaling regulates circulating ghrelin during acute inflammation. / Madison, Lisa D.; Scarlett, Jarrad M.; Levasseur, Peter; Zhu, XinXia; Newcomb, Kenneth; Batra, Ayesha; Bowe, Darren; Marks, Daniel.

In: Journal of Endocrinology, Vol. 196, No. 2, 02.2008, p. 263-273.

Research output: Contribution to journalArticle

Madison, LD, Scarlett, JM, Levasseur, P, Zhu, X, Newcomb, K, Batra, A, Bowe, D & Marks, D 2008, 'Prostacyclin signaling regulates circulating ghrelin during acute inflammation', Journal of Endocrinology, vol. 196, no. 2, pp. 263-273. https://doi.org/10.1677/JOE-07-0478
Madison LD, Scarlett JM, Levasseur P, Zhu X, Newcomb K, Batra A et al. Prostacyclin signaling regulates circulating ghrelin during acute inflammation. Journal of Endocrinology. 2008 Feb;196(2):263-273. https://doi.org/10.1677/JOE-07-0478
Madison, Lisa D. ; Scarlett, Jarrad M. ; Levasseur, Peter ; Zhu, XinXia ; Newcomb, Kenneth ; Batra, Ayesha ; Bowe, Darren ; Marks, Daniel. / Prostacyclin signaling regulates circulating ghrelin during acute inflammation. In: Journal of Endocrinology. 2008 ; Vol. 196, No. 2. pp. 263-273.
@article{6ecc73db86ce4474a1637a7b661dd1c0,
title = "Prostacyclin signaling regulates circulating ghrelin during acute inflammation",
abstract = "Ghrelin is an octanoylated 28 amino acid peptide predominantly secreted by the stomach, and has potent stimulatory effects on appetite. Several laboratories, including our own, have demonstrated that ghrehn levels fall in states of acute inflammation brought about by injection of bacterial lipopolysaccharide (LPS). We now demonstrate that the decrease in circulating ghrelin is not due to a decrease in ghrelin gene expression, but is instead likely to be due to an acute decrease in ghrelin secretion. Furthermore, we have found that the change in circulating ghrelin during acute inflammation required a prostaglandin second messenger, but did not require the synthesis of nitric oxide. Interestingly, i.v. injection of prostaglandin E2 failed to decrease circulating ghrelin levels, whereas prostacyclin decreased circulating ghrelin to a similar extent as did LPS. We also provide anatomical evidence for the mechanism of the regulation of ghrelin by inflammation. We demonstrate that the type 1 interleukin-1β (IL-1β) receptor is expressed within the gastric mucosa, but is not expressed by ghrelin cells. The prostacyclin receptor was also expressed in the gastric mucosa, and the majority of ghrelin-producing cells were found to co-express this receptor. Mice with genetic deletion of the type 1 IL-1 receptor do not suppress circulating ghrelin levels with LPS administration. Collectively, these data support a model in which the mechanism of inflammation induced decreases in ghrelin are due to the action of IL-1β on cells within the gastric mucosa that in turn produce prostacyclin as a second messenger. These data provide further support for the potential role of ghrelin as a therapeutic agent in acute and chronic inflammatory diseases.",
author = "Madison, {Lisa D.} and Scarlett, {Jarrad M.} and Peter Levasseur and XinXia Zhu and Kenneth Newcomb and Ayesha Batra and Darren Bowe and Daniel Marks",
year = "2008",
month = "2",
doi = "10.1677/JOE-07-0478",
language = "English (US)",
volume = "196",
pages = "263--273",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "2",

}

TY - JOUR

T1 - Prostacyclin signaling regulates circulating ghrelin during acute inflammation

AU - Madison, Lisa D.

AU - Scarlett, Jarrad M.

AU - Levasseur, Peter

AU - Zhu, XinXia

AU - Newcomb, Kenneth

AU - Batra, Ayesha

AU - Bowe, Darren

AU - Marks, Daniel

PY - 2008/2

Y1 - 2008/2

N2 - Ghrelin is an octanoylated 28 amino acid peptide predominantly secreted by the stomach, and has potent stimulatory effects on appetite. Several laboratories, including our own, have demonstrated that ghrehn levels fall in states of acute inflammation brought about by injection of bacterial lipopolysaccharide (LPS). We now demonstrate that the decrease in circulating ghrelin is not due to a decrease in ghrelin gene expression, but is instead likely to be due to an acute decrease in ghrelin secretion. Furthermore, we have found that the change in circulating ghrelin during acute inflammation required a prostaglandin second messenger, but did not require the synthesis of nitric oxide. Interestingly, i.v. injection of prostaglandin E2 failed to decrease circulating ghrelin levels, whereas prostacyclin decreased circulating ghrelin to a similar extent as did LPS. We also provide anatomical evidence for the mechanism of the regulation of ghrelin by inflammation. We demonstrate that the type 1 interleukin-1β (IL-1β) receptor is expressed within the gastric mucosa, but is not expressed by ghrelin cells. The prostacyclin receptor was also expressed in the gastric mucosa, and the majority of ghrelin-producing cells were found to co-express this receptor. Mice with genetic deletion of the type 1 IL-1 receptor do not suppress circulating ghrelin levels with LPS administration. Collectively, these data support a model in which the mechanism of inflammation induced decreases in ghrelin are due to the action of IL-1β on cells within the gastric mucosa that in turn produce prostacyclin as a second messenger. These data provide further support for the potential role of ghrelin as a therapeutic agent in acute and chronic inflammatory diseases.

AB - Ghrelin is an octanoylated 28 amino acid peptide predominantly secreted by the stomach, and has potent stimulatory effects on appetite. Several laboratories, including our own, have demonstrated that ghrehn levels fall in states of acute inflammation brought about by injection of bacterial lipopolysaccharide (LPS). We now demonstrate that the decrease in circulating ghrelin is not due to a decrease in ghrelin gene expression, but is instead likely to be due to an acute decrease in ghrelin secretion. Furthermore, we have found that the change in circulating ghrelin during acute inflammation required a prostaglandin second messenger, but did not require the synthesis of nitric oxide. Interestingly, i.v. injection of prostaglandin E2 failed to decrease circulating ghrelin levels, whereas prostacyclin decreased circulating ghrelin to a similar extent as did LPS. We also provide anatomical evidence for the mechanism of the regulation of ghrelin by inflammation. We demonstrate that the type 1 interleukin-1β (IL-1β) receptor is expressed within the gastric mucosa, but is not expressed by ghrelin cells. The prostacyclin receptor was also expressed in the gastric mucosa, and the majority of ghrelin-producing cells were found to co-express this receptor. Mice with genetic deletion of the type 1 IL-1 receptor do not suppress circulating ghrelin levels with LPS administration. Collectively, these data support a model in which the mechanism of inflammation induced decreases in ghrelin are due to the action of IL-1β on cells within the gastric mucosa that in turn produce prostacyclin as a second messenger. These data provide further support for the potential role of ghrelin as a therapeutic agent in acute and chronic inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=39749130253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749130253&partnerID=8YFLogxK

U2 - 10.1677/JOE-07-0478

DO - 10.1677/JOE-07-0478

M3 - Article

VL - 196

SP - 263

EP - 273

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 2

ER -